Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,836 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?
Eiwegger T, Anagnostou K, Arasi S, Bégin P, Ben-Shoshan M, Beyer K, Blumchen K, Brough H, Caubet JC, Chan ES, Chen M, Chinthrajah S, Davis CM, Des Roches A, Du Toit G, Elizur A, Galli SJ, Håland G, Hoffmann-Sommergruber K, Kim H, Leung DYM, Long A, Muraro A, Nurmatov UB, Pajno GB, Sampath V, Saxena J, Sindher S, Upton J, Worm M, Nadeau KC. Eiwegger T, et al. Among authors: long a. J Allergy Clin Immunol. 2020 Apr;145(4):1153-1156. doi: 10.1016/j.jaci.2019.10.021. Epub 2019 Nov 1. J Allergy Clin Immunol. 2020. PMID: 31678426 No abstract available.
Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
Andorf S, Purington N, Block WM, Long AJ, Tupa D, Brittain E, Rudman Spergel A, Desai M, Galli SJ, Nadeau KC, Chinthrajah RS. Andorf S, et al. Among authors: long aj. Lancet Gastroenterol Hepatol. 2018 Feb;3(2):85-94. doi: 10.1016/S2468-1253(17)30392-8. Epub 2017 Dec 12. Lancet Gastroenterol Hepatol. 2018. PMID: 29242014 Free PMC article. Clinical Trial.
The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses.
Sindher SB, Long A, Acharya S, Sampath V, Nadeau KC. Sindher SB, et al. Among authors: long a. Clin Rev Allergy Immunol. 2018 Oct;55(2):190-204. doi: 10.1007/s12016-018-8678-z. Clin Rev Allergy Immunol. 2018. PMID: 29455358 Free PMC article. Review.
By driving a complex range of changes in the underlying immune response, immunotherapy is the only therapy that modulates the immune system with long-term effects and is presently utilized for the treatment of several atopic conditions. ...While several markers have …
By driving a complex range of changes in the underlying immune response, immunotherapy is the only therapy that modulates the immune …
Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges.
Purington N, Chinthrajah RS, Long A, Sindher S, Andorf S, O'Laughlin K, Woch MA, Scheiber A, Assa'ad A, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Galli SJ, Desai M, Nadeau KC. Purington N, et al. Among authors: long a. Front Immunol. 2018 Sep 21;9:2057. doi: 10.3389/fimmu.2018.02057. eCollection 2018. Front Immunol. 2018. PMID: 30298065 Free PMC article. Clinical Trial.
Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple Allergens.
Sindher S, Long AJ, Purington N, Chollet M, Slatkin S, Andorf S, Tupa D, Kumar D, Woch MA, O'Laughlin KL, Assaad A, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Galli SJ, Nadeau KC, Chinthrajah RS. Sindher S, et al. Among authors: long aj. Front Immunol. 2018 Nov 27;9:2689. doi: 10.3389/fimmu.2018.02689. eCollection 2018. Front Immunol. 2018. PMID: 30538699 Free PMC article.
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals.
Andorf S, Purington N, Kumar D, Long A, O'Laughlin KL, Sicherer S, Sampson H, Cianferoni A, Whitehorn TB, Petroni D, Makhija M, Robison RG, Lierl M, Logsdon S, Desai M, Galli SJ, Rael E, Assa'ad A, Chinthrajah S, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Nadeau K. Andorf S, et al. Among authors: long a. EClinicalMedicine. 2019 Jan 21;7:27-38. doi: 10.1016/j.eclinm.2018.12.006. eCollection 2019 Jan. EClinicalMedicine. 2019. PMID: 31193674 Free PMC article.
The future of omics for clinical practice.
Long A, Bunning B, Borro M, Sampath V, Nadeau KC. Long A, et al. Ann Allergy Asthma Immunol. 2019 Dec;123(6):535-536. doi: 10.1016/j.anai.2019.07.016. Epub 2019 Jul 26. Ann Allergy Asthma Immunol. 2019. PMID: 31351978 No abstract available.
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
Chinthrajah RS, Purington N, Andorf S, Long A, O'Laughlin KL, Lyu SC, Manohar M, Boyd SD, Tibshirani R, Maecker H, Plaut M, Mukai K, Tsai M, Desai M, Galli SJ, Nadeau KC. Chinthrajah RS, et al. Among authors: long a. Lancet. 2019 Oct 19;394(10207):1437-1449. doi: 10.1016/S0140-6736(19)31793-3. Epub 2019 Sep 12. Lancet. 2019. PMID: 31522849 Free PMC article. Clinical Trial.
We evaluated the sustained effects of peanut allergy oral immunotherapy (OIT) in a randomised long-term study in adults and children. METHODS: In this randomised, double-blind, placebo-controlled, phase 2 study, we enrolled participants at the Sean N Parker Center f …
We evaluated the sustained effects of peanut allergy oral immunotherapy (OIT) in a randomised long-term study in adults and ch …
Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.
Chinthrajah S, Cao S, Liu C, Lyu SC, Sindher SB, Long A, Sampath V, Petroni D, Londei M, Nadeau KC. Chinthrajah S, et al. Among authors: long a. JCI Insight. 2019 Nov 14;4(22):e131347. doi: 10.1172/jci.insight.131347. JCI Insight. 2019. PMID: 31723064 Free PMC article. Clinical Trial.
1,836 results